These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1204508)

  • 1. Treatment of respiratory infections.
    Burns MW
    Drugs; 1975; 10(5-6):437-50. PubMed ID: 1204508
    [No Abstract]   [Full Text] [Related]  

  • 2. [What are the errors to be avoided in the treatment of respiratory infections?].
    Germouty J; Bonnaud F; Gay G
    Sem Hop Ther; 1977 Apr; 53(4):245-8. PubMed ID: 882869
    [No Abstract]   [Full Text] [Related]  

  • 3. [Variations of microbial sensitivity in lower respiratory tract infections].
    Aguerre MM; Costa de Mello B
    Hoja Tisiol; 1971; 28(1-2):41-76. PubMed ID: 5173683
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibiotic use for infective terminal respiratory secretions.
    Spruyt O; Kausae A
    J Pain Symptom Manage; 1998 May; 15(5):263-4. PubMed ID: 9654826
    [No Abstract]   [Full Text] [Related]  

  • 5. [On some characteristics of staphylococci isolated from the sputum before and after therapy with erythromycin].
    Lo Curto RB; Pernice A; Alonzo V
    G Batteriol Virol Immunol Microbiol; 1973; 66(7-12):269-75. PubMed ID: 4802277
    [No Abstract]   [Full Text] [Related]  

  • 6. Current microbiological data on lower respiratory tract infection in cystic fibrosis. Part II: Recommendations for microbiological diagnosis in cystic fibrosis.
    Coman G; Petraru E; Dahorea C; Anton DT
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(3):898-901. PubMed ID: 23272549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sensitivity to staphylomycin of the bacterial flora isolated from expectorate in the course of various bronchopneumopathies].
    Gialdroni Grassi G; Fornaroli E
    G Ital Chemioter; 1967; 14(1):70-4. PubMed ID: 4908139
    [No Abstract]   [Full Text] [Related]  

  • 8. [Tracheal puncture for study of bacterial flora in infectious lung diseases].
    Schoutens E; De Koster JP; Arouete A; Tombroff M; Yourassowsky E
    Acta Clin Belg; 1971; 26(2):78-94. PubMed ID: 5142049
    [No Abstract]   [Full Text] [Related]  

  • 9. [In vitro susceptibility to antifungal agents of Candida strains isolated from patients with various diseases of the respiratory tract].
    Batura-Gabryel H; Wieczorek U; Mlynarczyk W
    Pneumonol Alergol Pol; 1997; 65(5-6):355-9. PubMed ID: 9340063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibacterial activity of carbapenems against clinically isolated respiratory bacterial pathogens in Japan between 2003 and 2004.
    Watanabe A; Tokue Y; Kikuchi T; Gomi K; Aoki S; Satoh T; Fujimura S
    Int J Antimicrob Agents; 2005 Nov; 26(5):420-3. PubMed ID: 16216468
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of selected antibiotics on Gram-negative bacteria isolated from the upper respiratory tract of patients with respiratory diseases].
    Jastalska D; Gralewicz J; Lupicki W; Chojnowski W
    Pol Tyg Lek; 1982 Sep; 37(36):1041-8. PubMed ID: 7170256
    [No Abstract]   [Full Text] [Related]  

  • 12. [Biological characteristics of microorganisms of the Haemophilus group isolated in infections of the lower respiratory tract].
    Dorobăţ O; Romanoff E; Lăzăroae D; Ceauşu E; Erşcoiu S
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1986; 31(3):209-18. PubMed ID: 3787083
    [No Abstract]   [Full Text] [Related]  

  • 13. [Value of quantitative bacteriological examination of sputum in the evaluation of the effectiveness of chemotherapy of bacterial respiratory tract infections. I. Bacteriological studies].
    Przybyłkiewicz Z; Nikodemowicz E; Kasprowicz A; Owsiński J
    Pneumonol Pol; 1980 Aug; 48(8):535-43. PubMed ID: 6775309
    [No Abstract]   [Full Text] [Related]  

  • 14. [Practical importance of quantitative bacteriology in pneumology. Preliminary studies].
    Corda M
    Ann Sclavo; 1975; 17(3):354-84. PubMed ID: 779672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effect of ofloxacin on acute exacerbations of chronic respiratory tract infections in comparison with erythromycin.
    Kawahara S; Watanabe Y; Matsuka Y; Sato T; Takahashi K
    Drugs; 1995; 49 Suppl 2():414-5. PubMed ID: 8549382
    [No Abstract]   [Full Text] [Related]  

  • 16. Chapter 2-1. Anaerobic infections (individual fields): respiratory infections.
    ;
    J Infect Chemother; 2011 Jul; 17 Suppl 1():42-6. PubMed ID: 21728090
    [No Abstract]   [Full Text] [Related]  

  • 17. [Continued or discontinued administration of antimicrobial agents in patients of the CARA group].
    Sluiter HJ
    Ned Tijdschr Geneeskd; 1976 Jul; 120(31):1337-9. PubMed ID: 7756
    [No Abstract]   [Full Text] [Related]  

  • 18. Successful treatment of respiratory tract infections in patients with chronic respiratory disease-how to make objective conclusions.
    Pines A
    J Antimicrob Chemother; 1982 Mar; 9(3):165-8. PubMed ID: 7076601
    [No Abstract]   [Full Text] [Related]  

  • 19. Antibiotics and purulent sputum.
    Howie JG
    Br Med J; 1976 Oct; 2(6040):882. PubMed ID: 990740
    [No Abstract]   [Full Text] [Related]  

  • 20. Antimicrobial screening of Nicotiana tobacum on organisms isolated from patients with respiratory tract infection.
    Adeleye IA; Uwagboe UC
    West Indian Med J; 2003 Dec; 52(4):325-6. PubMed ID: 15040073
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.